Utilization of Allogeneic Liver Progenitor Cells Expanded from Adult Healthy Human Livers to Treat Genetic Disorders

CellTherapy-PrometheraPromethera Biosciences presents this case study detailing how HHALPC from normal adult livers can be purified, expanded In vitro and utilized to successfully treat patients with Crigler-Najjar disease.
Speaker:
Eric Halioua, Chief Executive Officer, Promethera Biosciences

 

Listen to the audio cast here

Leave a Reply